## **Core Concept**
Hyperacute rejection is a type of organ transplant rejection that occurs almost immediately after transplantation. It is primarily mediated by pre-existing antibodies in the recipient against the donor organ. This type of rejection is most commonly seen in kidney transplants.

## **Why the Correct Answer is Right**
The correct answer, , involves pre-formed antibodies against the donor's endothelial cells, leading to immediate activation of complement, thrombosis, and ischemia of the graft. This process is extremely rapid, often occurring within minutes to hours after the transplant. The antibodies are usually against ABO blood group antigens or human leukocyte antigens (HLA) present on the endothelial cells of the graft.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while T-cell mediated immunity plays a crucial role in acute and chronic rejection, it is not the primary mechanism behind hyperacute rejection.
- **Option B:** This option is incorrect as it does not directly relate to the immediate antibody-mediated response characteristic of hyperacute rejection.
- **Option C:** This option, although related to immune responses, does not accurately describe the primary cause of hyperacute rejection.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that hyperacute rejection is often due to ABO incompatibility or sensitization to HLA antigens. This can sometimes be mitigated by cross-matching donor and recipient blood before transplant. Despite this, hyperacute rejection remains a serious and immediate threat to graft survival.

## **Correct Answer:** . Pre-formed antibodies.